Image

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

Recruiting
14 years and older
All
Phase N/A

Powered by AI

Overview

First-degree relatives of people with inflammatory bowel disease ("IBD," including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow unaffected first-degree relatives (who do not have IBD) over time to understand if their behaviors, diet, and biomarkers for IBD can help predict who gets IBD and if IBD can be prevented in these high-risk individuals. Participants will be asked once per year to complete a questionnaire and have their blood, stool, and urine collected. The anticipated length of the study (registry) is approximately 10 years or longer. Parts of this study, such as the questionnaires and stool and urine collection, may be done from home, while other parts, such as the blood draw, will need to be done from Massachusetts General Hospital.

Eligibility

Inclusion Criteria:

  • Ability to give informed consent
  • Ability to complete all study visits and study-related procedures
  • Ability to understand and complete study questionnaires
  • Must have at least one first-degree relative with inflammatory bowel disease (Crohn's disease, ulcerative colitis, or IBD-unclassified)
  • Age ≥ 14

Exclusion Criteria:

  • Individuals with existing diagnoses of inflammatory bowel disease (ulcerative colitis, Crohn's disease, or IBD-unclassified)
  • Evidence of clinical signs or symptoms of IBD, which will be identified on pre-screening interview with the study coordinator.

Study details
    Inflammatory Bowel Disease (IBD)
    Ulcerative Colitis (UC)
    IBD-unclassified (IBD-U)
    Indeterminate Colitis
    Crohn's Disease Colon
    Crohn's Colitis
    Crohn's Ileocolitis
    Crohn's Gastritis
    Crohn's Jejunitis
    Crohn's Duodenitis
    Crohn's Esophagitis
    Ulcerative Proctitis
    Ulcerative Proctosigmoiditis

NCT06655415

Massachusetts General Hospital

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.